References
- Bennett JM, Catovsky D, Daniel MT, et al. Proposals for the classification of the myelodysplastic syndromes. Br J Haematol 1982;51:189–199.
- Cazzola M, Malcovati L. Myelodysplastic syndromes-coping with ineffective hematopoiesis. N Engl J Med 2005;352:536–538.
- Demeter J, Messer G, Schrezenmeier H. Clinical relevance of the TNF-alpha promoter/enhancer polymorphism in patients with aplastic anemia. Ann Hematol 2002;81:566–569.
- Seidemann K, Zimmermann M, Book M, et al. Tumor necrosis factor and lymphotoxin alfa genetic polymorphisms and outcome in pediatric patients with non-Hodgkin's lymphoma: results from Berlin-Frankfurt-Münster Trial NHL-BFM 95. J Clin Oncol 2005; 23:8414–8421.
- Kádár K, Kovács M, Karádi I, et al. Polymorphisms of TNF- alpha and LT-alpha genes in multiple myeloma. Leuk Res 2008;32: 1499–1504.
- Jevtovic-Stoimenov T, Kocic G, Pavlovic D, et al. Polymorphisms of tumor-necrosis factor-alpha-308 and lymphotoxin-alpha + 250: possible modulation of susceptibility to apoptosis in chronic lymphocytic leukemia and non-Hodgkin lymphoma mononuclear cells. Leuk Lymphoma 2008;49:2163–2169.
- Ibrahim A, Abdel Rahman H, Khorshied M, et al. Tumor necrosis factor alpha-308 and lymphotoxin alpha + 252 genetic polymorphisms and the susceptibility to non-Hodgkin lymphoma in Egypt. Leuk Res 2012;36:694–698.
- Warzocha K, Ribeiro P, Bienvenu J, et al. Genetic polymorphisms in the tumor necrosis factor locus influence non-Hodgkin's lymphoma outcome. Blood 1998;91:3574–3581.
- Demeter J, Porzsolt F, Ramisch S, et al. Polymorphism of the tumour necrosis factor-alpha and lymphotoxin-alpha genes in chronic lymphocytic leukaemia. Br J Haematol 1997;97:107–112.
- Neben K, Mytilineos J, Moehler TM, et al. Polymorphisms of the tumor necrosis factor-alpha gene promoter predict for outcome after thalidomide therapy in relapsed and refractory multiple myeloma. Blood 2002;100:2263–2265.
- Belli CB, Bestach Y, Sieza Y, et al. The presence of -308A TNFα is associated with anemia and thrombocytopenia in patients with myelodysplastic syndromes. Blood Cells Mol Dis 2011;47:255–258.
- Kádár K, Demeter J, Andrikovics H, et al. TNF-alpha promoter gene polymorphism in patients with myelodysplastic syndrome. Acta Haematol 2005;113:262–264.
- Li L, Yang L, Zhang Y, et al. Detoxification and DNA repair genes polymorphisms and susceptibility of primary myelodysplastic syndromes in Chinese population. Leuk Res 2011;35:762–765.
- Qu S, Xu Z, Zhang Y, et al. The impacts of the cytogenetic categories in the Revised International Prognostic Scoring System on the prognosis of primary myelodysplastic syndromes: results of a single-center study. Leuk Lymphoma 2012;53:940–946.